AURPHIE Life sciences SPRL
Dissolution judiciaire ou nullitéAURPHIE Life sciences reported total assets of 344,213 € at the end of the 2021 financial year (annual accounts filed with the NBB on 19 Aug 2022).
The score of AURPHIE Life sciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2021
Change 2018 → 2021: Equity +104 % Total assets +45 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AURPHIE Life sciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2021filed on 19 Aug 2022
- Year ended 31 Dec 2020filed on 13 Dec 2021
- Year ended 31 Dec 2019filed on 30 Oct 2020
- Year ended 31 Dec 2018filed on 27 Aug 2019
- Year ended 31 Dec 2017filed on 14 Sep 2018
AURPHIE Life sciences's financial analysis
- Solvency6.0%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AURPHIE Life sciences
AURPHIE Life sciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0651.901.663
- VAT number
- BE0651901663
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 14 Apr 2016
- Registered office
- 1050 Ixelles
- Latest accounts
- 2021 · filed on 19 Aug 2022
- Activity
- Activities of holding companies (NACE 64210)
AURPHIE Life sciences (SPRL) has been based in Ixelles since 2016, active in: activities of holding companies. For 2021, it reports a net profit of 5,277 € and equity of 20,596 €; its revenue is not published. Its solvency stands at 6.0%, below the median of its sector (60.1%).
Companies similar to AURPHIE Life sciences
Companies in the same business, of comparable size and area, outside its group.
- Penta Invest Joinery installation Saint-Ghislain · balance sheet 344,182 €
- Paca1 Activities of holding companies Sint-Martens-Latem · balance sheet 344,314 €
- Tim Holding Geetbets · balance sheet 344,359 €
- Dr. C. Dielen Medical specialists activities Hove · balance sheet 344,016 €
- GenomiX Activities of holding companies Liège · balance sheet 343,875 €
- Levin Activities of holding companies Houthalen-Helchteren · balance sheet 344,602 €
- Alliance 4 Activities of holding companies Braine-l'Alleud · balance sheet 344,669 €
- Life & Finance Management Ottignies-Louvain-la-Neuve · balance sheet 344,678 €
Frequently asked questions about AURPHIE Life sciences
What is the revenue of AURPHIE Life sciences?
AURPHIE Life sciences files its accounts in a format where revenue is optional: it is not published for 2021.
What is the VAT number of AURPHIE Life sciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0651901663 for AURPHIE Life sciences, if the company is VAT-registered. Its company number (CBE) is 0651.901.663.
Where is the registered office of AURPHIE Life sciences?
According to the CBE register, the registered office of AURPHIE Life sciences is in 1050 Ixelles.
What is the equity of AURPHIE Life sciences?
At the close of the 2021 financial year, the equity of AURPHIE Life sciences amounts to 20,596 €, a solvency of 6.0% of total assets.
Who manages AURPHIE Life sciences?
The register lists 2 active mandates at AURPHIE Life sciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AURPHIE Life sciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →